Sacubitril valsartan tablets, known as sacubitril valsartan sodium tablets, and metoprolol, generally referred to as metoprolol tartrate tablets or metoprolol succinate extended-release tablets, can be taken together to intensify the effects of the drug. It is contraindicated in pregnant women, lactating women, patients with low blood pressure and those with drug allergies.
Sacubitril valsartan sodium tablets belong to the cardiovascular type of medication and contain enkephalinase inhibitors and angiotensin receptor antagonists for the treatment of chronic heart failure. Metoprolol tablets belong to the category of beta-blockers and are used to treat high blood pressure, angina pectoris, and myocardial infarction. The two drugs can be taken together and have a reinforcing and complementary effect on the treatment of hypertension.
Sacubitril valsartan sodium tablets and metoprolol tablets are contraindicated in pregnant as well as lactating women to avoid effects on fetal as well as infant development. Sacubitril valsartan sodium tablets and metoprolol tablets are contraindicated in patients with low blood pressure, which may lead to dizziness and respiratory difficulties. It is contraindicated for those who are allergic to the ingredients of both drugs to prevent adverse reactions such as generalized rash and shock.
Sacubitril valsartan sodium tablets and metoprolol tablets can be taken at the same time, patients should follow the doctor’s instructions to use the drug, not blindly use the drug.